title: Survivin mRNA in peripheral blood is frequently detected and significantly decreased following resection of gastrointestinal cancers.
abstract: OBJECTIVE
  We evaluated if mRNA expression of survivin, an inhibitor of apoptosis, can be used to detect circulating tumor cells in peripheral blood of patients with various gastrointestinal cancers and if they decrease following complete surgical resection.
  
  
  METHODS
  Blood samples from 40 gastrointestinal cancer patients were analyzed prior and following surgical resection by direct quantitative real-time reverse transcriptase-PCR (RT-PCR) assays.
  
  
  RESULTS
  Survivin mRNA expression was pre-operatively detected in 35 of 40 cancer patients (88%). Post-operative survivin levels were significantly lower than pre-operative levels in 59% of resected patients and were non-detectable in 38% (Wilcoxon rank test: P < 0.04).
  
  
  CONCLUSIONS
  This is the first report showing that direct quantitative real-time RT-PCR analysis of survivin mRNA expression in peripheral blood of patients with gastrointestinal cancers is technically feasible. Survivin mRNA levels fall significantly following complete resection and might become a molecular marker for the completeness of surgical resection.
authors.affiliation: Department of Visceral and Vascular Surgery, University of Cologne, Cologne, Germany.
authors.forename: A-C
authors.initials: AC
authors.lastname: Hoffmann
authors.forename: U
authors.initials: U
authors.lastname: Warnecke-Eberz
authors.forename: T
authors.initials: T
authors.lastname: Luebke
authors.forename: K
authors.initials: K
authors.lastname: Prenzel
authors.forename: R
authors.initials: R
authors.lastname: Metzger
authors.forename: M
authors.initials: M
authors.lastname: Heitmann
authors.forename: S
authors.initials: S
authors.lastname: Neiss
authors.forename: D
authors.initials: D
authors.lastname: Vallbohmer
authors.forename: A H
authors.initials: AH
authors.lastname: Hoelscher
authors.forename: P M
authors.initials: PM
authors.lastname: Schneider
mesh_terms: D000230:Adenocarcinoma / Q000378:metabolism* / Q000556:secondary / Q000601:surgery; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000097:blood; D005260:Female; D005770:Gastrointestinal Neoplasms / Q000378:metabolism* / Q000473:pathology / Q000601:surgery; D006801:Humans; D051034:Inhibitor of Apoptosis Proteins / Q000096:biosynthesis* / Q000097:blood; D008207:Lymphatic Metastasis; D008297:Male; D008869:Microtubule-Associated Proteins / Q000096:biosynthesis* / Q000097:blood; D008875:Middle Aged; D009363:Neoplasm Proteins / Q000096:biosynthesis* / Q000097:blood; D009360:Neoplastic Cells, Circulating / Q000378:metabolism; D012333:RNA, Messenger / Q000096:biosynthesis / Q000097:blood; D020133:Reverse Transcriptase Polymerase Chain Reaction; D000077022:Survivin
chemical_list: C107489:BIRC5 protein, human; D014408:Biomarkers, Tumor; D051034:Inhibitor of Apoptosis Proteins; D008869:Microtubule-Associated Proteins; D009363:Neoplasm Proteins; D012333:RNA, Messenger; D000077022:Survivin